Skip to content

Clinical and molecular features of Epidermal Growth Factor Receptor (EGFR) mutation positive non-small-cell lung cancer patients treated with tyrosine kinase inhibitors: predictive and prognostic role of co-mutations

· 0 citations · 59 references
View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.